# Mechanism - Distance Threshold 0.7\n\nExperiment: threshold_0.7_mechanisms\nTotal clusters: 130\nSingleton clusters: 0 (0.0%)\nSilhouette score: 0.134\nDavies-Bouldin score: 0.666\n\n================================================================================\n\n## Cluster 28: Behavioral Adherence through Education and Monitoring\n\n**Category**: Behavioral Intervention\n**Members**: 5\n\n- behavioral adherence improvement through education and follow-up\n- enhanced adherence and monitoring\n- enhanced adherence and monitoring through video observation\n- enhanced behavioral adherence and patient engagement\n- enhanced medication adherence through reminders\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 55: cognitive training enhancement\n\n**Category**: neurocognitive modulation\n**Members**: 4\n\n- cognitive function improvement through multi-domain training\n- enhanced cognitive function through computerized training\n- enhanced cognitive function through gamified training\n- enhanced cognitive function through personalized training\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 0: Emotional and Social Engagement Enhancement\n\n**Category**: Social and Psychological Engagement\n**Members**: 3\n\n- emotional engagement and social interaction\n- enhanced engagement through tailored linguistic and demographic features\n- enhanced psychological and social engagement\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 1: Exercise and Psychological Support Integration\n\n**Category**: Psychological and Physical Rehabilitation\n**Members**: 3\n\n- combining exercise and psychological support based on broaden-and-build theory\n- enhanced exercise capacity and reduced stress/anxiety\n- enhanced psychological adaptation and improved functional recovery\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 6: Cardiac function assessment during stress\n\n**Category**: diagnostic evaluation\n**Members**: 3\n\n- assessment of cardiac response during physical exertion\n- assessment of left ventricular function during stress\n- evaluation of myocardial blood flow during stress\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 7: Cell Cycle Arrest and Apoptosis Induction in Tumor Cells\n\n**Category**: anti-cancer\n**Members**: 3\n\n- cell cycle arrest and apoptosis induction in tumor cells\n- cell cycle inhibition and DNA damage\n- cell cycle inhibition and apoptosis induction in tumor cells\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 8: Bone Density Improvement and Pain Reduction\n\n**Category**: Metabolic Regulation\n**Members**: 3\n\n- bone density increase\n- bone mineral density improvement and pain alleviation\n- enhance bone metabolism and improve bone quality\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 17: Antibiotic treatment for H. pylori eradication\n\n**Category**: antimicrobial\n**Members**: 3\n\n- antibiotic treatment to eradicate H. pylori\n- antibiotic treatment to eradicate H. pylori in a sequential regimen\n- antibiotic treatment to eradicate H. pylori resistant to other antibiotics\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 20: Cognitive Stimulation and Brain Connectivity Enhancement\n\n**Category**: Neurocognitive Modulation\n**Members**: 3\n\n- cognitive stimulation and improved cognitive performance\n- enhanced brain functional connectivity and cognitive improvements\n- enhanced cognitive engagement and neural stimulation\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 22: Engagement through Physical and Cognitive Activities\n\n**Category**: Behavioral Motivation\n**Members**: 3\n\n- engagement through structured physical and cognitive activities\n- enhanced engagement and motivation through interactive gameplay\n- enhanced engagement in rewarding activities\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 27: Cognitive Rehabilitation via Structured Exercises\n\n**Category**: Neurorehabilitation\n**Members**: 3\n\n- enhanced cognitive function through structured rehabilitation\n- enhanced cognitive performance through aerobic and integrated physical activities\n- enhanced cognitive rehabilitation through interactive exercises\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 37: urinary acidification via metabolic pathways\n\n**Category**: metabolic regulation\n**Members**: 3\n\n- decreased urinary pH through acid excretion\n- decreased urinary pH through increased acid load\n- decreased urinary pH through sulfur metabolism\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 2: Vaccination Adherence via Digital Engagement\n\n**Category**: Behavioral Intervention\n**Members**: 2\n\n- enhanced communication and targeted information delivery to improve vaccination adherence\n- enhanced motivation and adherence through digital engagement\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 3: Clot Dissolution via Thrombolysis and Mechanical Removal\n\n**Category**: Cardiovascular\n**Members**: 2\n\n- clot dissolution through systemic administration of thrombolytic agents\n- combination of mechanical clot removal and pharmacological thrombolysis\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 5: Minimally Invasive Stone Removal\n\n**Category**: Surgical Intervention\n**Members**: 2\n\n- direct stone removal through minimally invasive surgical access\n- endoscopic removal of stones from the ureter\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 10: Cognitive Behavioral Therapy for Anxiety and Substance Use\n\n**Category**: mental health intervention\n**Members**: 2\n\n- behavioral therapy for mental health improvement\n- cognitive behavioral techniques targeting anxiety and substance use behaviors\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 12: cardiac function and hemodynamic enhancement\n\n**Category**: cardiovascular regulation\n**Members**: 2\n\n- enhanced cardiac function and hemodynamic stability\n- enhancement of cardiac contractility\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 13: Psychological Resilience and Immune Enhancement\n\n**Category**: Psychological and Immune Regulation\n**Members**: 2\n\n- alleviation of psychological distress and enhancement of immune function\n- enhances psychological resilience and coping strategies\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 15: Antibacterial action against Mycobacterium tuberculosis\n\n**Category**: antimicrobial\n**Members**: 2\n\n- antibacterial action against Mycobacterium tuberculosis\n- combined antibacterial action against Mycobacterium tuberculosis\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 16: Neural Pain Modulation\n\n**Category**: Analgesic\n**Members**: 2\n\n- alleviates pain perception through neural modulation\n- enhanced pain thresholds and reduced pain sensitivity\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 18: bone-tendon regeneration via growth factors\n\n**Category**: tissue repair\n**Members**: 2\n\n- enhanced bone-tendon interface regeneration through increased platelet, nucleated cell, stem cell, TGFÎ²1, and IGF1 concentrations\n- enhanced tendon healing and improved structural integrity\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 23: Antibiotic and bismuth therapy with probiotics for H. pylori eradication\n\n**Category**: antimicrobial\n**Members**: 2\n\n- antibiotic treatment and bismuth to eradicate H. pylori\n- antibiotic treatment and bismuth to eradicate H. pylori, supplemented with probiotics\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 24: Corticosteroid-mediated anti-inflammatory effects\n\n**Category**: anti-inflammatory\n**Members**: 2\n\n- anti-inflammatory effects through corticosteroid action\n- corticosteroid-mediated anti-inflammatory effects\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 25: Anti-estrogenic and anti-inflammatory effects\n\n**Category**: anti-inflammatory\n**Members**: 2\n\n- anti-estrogenic and anti-inflammatory properties\n- anti-inflammatory properties\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 29: Cognitive Behavioral Therapy for Pain Management\n\n**Category**: pain management\n**Members**: 2\n\n- cognitive behavioral therapy for pain management\n- education on pain management, coping strategies, and goal setting\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 30: Chloride Channel Activation\n\n**Category**: Gastrointestinal Motility\n**Members**: 2\n\n- activates chloride channels in the intestinal epithelium to increase fluid secretion\n- activates guanylate cyclase-C receptors to increase intestinal fluid secretion\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 31: Anticoagulation to prevent thromboembolism\n\n**Category**: anti-thrombotic\n**Members**: 2\n\n- anticoagulation to prevent thromboembolic events\n- anticoagulation to prevent thrombus formation\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 34: renal replacement therapy timing adjustment\n\n**Category**: therapeutic intervention\n**Members**: 2\n\n- delayed initiation of renal replacement therapy\n- early initiation of renal replacement therapy\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 38: Cytotoxic Chemotherapy\n\n**Category**: Oncological\n**Members**: 2\n\n- cytotoxic chemotherapy\n- cytotoxic effects on cancer cells\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 41: bone turnover modulation\n\n**Category**: metabolic regulation\n**Members**: 2\n\n- accelerated bone turnover and bone loss\n- enhanced bone turnover and muscle function\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Remaining Clusters\n\nShowing top 30 of 100 total clusters. Remaining 70 clusters not shown (smaller clusters).\n\n